PDCD1 and hematologic disorder: Immune checkpoints, such as programmed cell death 1 (PD-1), its ligand (PD-L1), and cytotoxic T lymphocyte antigen 4 (CTLA-4), have been extensively studied because of their overexpression in many solid tumors and hematological malignancies (24, 25).